Older people and those with weakened immune systems may get a second dose of Omicron-targeting COVID-19 vaccines, the U.S. Centers for Disease Control and Prevention (CDC) said on Wednesday.
Over 300 biotech and pharmaceutical industry executives, including Pfizer Inc CEO Albert Bourla, signed an open letter on Monday calling for reversal of a federal judge's decision to suspend sales of the abortion pill mifepristone.
Arbutus Biopharma on Tuesday sued U.S. drugmaker Pfizer Inc and its German partner BioNTech SE in a New Jersey district court, claiming their mRNA COVID-19 vaccines infringe five of Arbutus' patents.
Cytokinetics Inc said on Friday it would focus on its heart disease treatment after its amyotrophic lateral sclerosis (ALS) drug failed a late-stage study.
A Texas judge blocked Obamacare's mandate that insurance plans cover preventive care, including pre-exposure prophylaxis against HIV and screenings for cancer, diabetes and depression at no cost to patients.